[mc4wp_form id="313"]

FDA OKs ‘Game-Changer’ Oral GLP-1 Agonist for Type 2 Diabetes

Share this post

Semaglutide is the first oral glucagon-like peptide-1 receptor agonist. Previously, drugs of this class were available only as injectables. The approval is expected to increase uptake.
FDA Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply